Pure Bioscience Raises $555K in Private Placement; Director Lee Funds Entire Round
PURE sits 87% above its 52-week low of $0.039.
Summary
Pure Bioscience raised $555,000 selling 10.18 million shares at $0.0545 to director Tom Y. Lee and affiliates — a related-party lifeline priced below today's market, with proceeds earmarked for R&D and working capital.
Key Events · Financing and Capital Events · PURE
-
Related-Party Private Placement Closes
On October 15, 2026 the company sold 10,183,486 shares at $0.0545 for $555,000; director Tom Y. Lee and affiliates funded the entire amount, and disinterested directors approved the deal.
-
Pricing Below Current Market
The $0.0545 purchase price is about 24% below today's $0.072 quote, so the new shares were sold at a discount to the prevailing market.
-
Proceeds and Use
Net proceeds are expected to be approximately $555,000 after fees, directed to R&D, general administrative expenses and working capital.
-
Dilution and Governance Overhang
The 10.18 million new shares add to a share base already expanded by prior dilutive financing; a single board member now holds a larger stake, concentrating ownership.
Analysis · PURE · Industrial Applications And Services
Pure Bioscience closed a $555,000 private placement on October 15, 2026, selling 10,183,486 shares at $0.0545 — roughly 24% below today's $0.072 quote. The entire round was funded by director Tom Y. Lee and his affiliates, with disinterested directors approving the related-party terms. That keeps the lights on for a company that previously disclosed going-concern doubt and a Q3 net loss, but it shifts more of the cap table to a single board member and adds meaningful dilution at a depressed price. The company says net proceeds are expected to be approximately $555,000, essentially the gross amount, and will go to R&D, general administrative expenses and working capital.
How filings like this one have moved
In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PURE was trading at $0.07 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9.4M. The 52-week trading range was $0.04 to $0.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.